DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
Transactions / OneroRx
Cyprium Completes Investment in OneroRx, Marking the Group’s 100th Platform Investment
Platform acquisitionclosedannounced Jan 25, 2024closed Jan 25, 2024Fact
What happened
- Target
- OneroRx
- Platform
- not an add-on on record
- Control
- Control
- Share acquired
- unknown
- Industry
- unknown
- Target location
- IA, US
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
3 named
Buy side
- ““I was incredibly impressed by the skill and dedication of OneroRx’s management team and employees,” said Beth Haas, a partner at Cyprium.”
- “Cyprium Partners, a middle-market private equity firm, is pleased to announce the firm’s 100th platform investment, a non-controlling investment in OneroRx.”
Side not stated
- “Cyprium Completes Investment in OneroRx, Marking the Group’s 100th Platform Investment”
Evidence
“Cyprium Completes Investment in OneroRx, Marking the Group’s 100th Platform Investment”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026